“Employers will add things to what they offer employees based upon what they hear their employees saying they want, especially in competitive job markets like we have right now,” says Paul Fronstin, director of health benefits research at the Employee Benefit Research Institute. “So in some respects, this fits in.”
While data to backup the effectiveness and safety of psychedelic-assisted therapy is still not plentiful, at least one company, Boston-based startup Enthea, wants to encourage self-insured employers to adopt these types of treatments.
Enthea’s CEO and co-founder Sherry Rais acknowledges that “there are still no standards of treatment and there’s still no way to create access.”
“That’s why Enthea is bridging these gaps,” Rais said. “There’s so much I’m excited about.”